Teomics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$50K
- Investors
-
2
Teomics General Information
Description
Operator of a discovery platform intended to accelerate life science research. The company's platform leverages technology to provide antigen retrieval solutions and detection kits using novel tissue immunohistochemistry and proteomics methods, enabling healthcare professionals to save time in the laboratory.
Contact Information
Website
www.teomics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Other Devices and Supplies
Primary Office
- 5000 Gulf Freeway
- Building 5 (114)
- Houston, TX 77023
- United States
+1 (800) 000-0000
Teomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 01-Jan-2016 | $50K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 12-Aug-2015 | Completed | Generating Revenue |
Teomics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jason Eriksen Ph.D | Co-Founder & Chief Executive Officer | ||
| Willy Moree Ph.D | Co-Founder |
Teomics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Teomics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Science Foundation | Government | 000 0000 | 000000 0 | ||
| RedLabs Accelerator | Accelerator/Incubator | 000 0000 | 000000 0 |